Progress on the role of melatonin in dilated cardiomyopathy
Dilated cardiomyopathy (DCM) is characterized by decreased systolic function and left or biventricular enlargement. There is no single specific medicine to delay the progression of DCM. Melatonin (Mel) plays a key role in many cardiovascular diseases by regulating cell damage, oxidative stress and o...
| Published in: | Jichu yixue yu linchuang |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | Chinese |
| Published: |
Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College.
2022-07-01
|
| Subjects: | |
| Online Access: | http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/1001-6325-2022-42-7-1148.pdf |
| Summary: | Dilated cardiomyopathy (DCM) is characterized by decreased systolic function and left or biventricular enlargement. There is no single specific medicine to delay the progression of DCM. Melatonin (Mel) plays a key role in many cardiovascular diseases by regulating cell damage, oxidative stress and other pathological processes,delaying myocardial remodeling and protecting cardiac function. There is a close relationship between DCM and Mel. It is confirmed that Mel plays an important role in delaying the progression of DCM. |
|---|---|
| ISSN: | 1001-6325 |
